Metagenomi, Inc. Common Stock (MGX) — Financial Flexibility Index
Metagenomi, Inc. Common Stock (MGX) has a Financial Flexibility Index of -0.36x as of March 2026. Free cash flow of $-21.15 Million (operating CF $-21.18 Million minus capex $25.00K) represents 0% of total liabilities ($59.17 Million). Check how strategically is Metagenomi, Inc. Common Stock's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Metagenomi, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Metagenomi, Inc. Common Stock across 5 annual periods. See MGX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Metagenomi, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Metagenomi, Inc. Common Stock. For the full company profile including market capitalisation, see MGX market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.41x | $-88.32 Million | $-88.89 Million | $62.51 Million | ▼ -19.7% |
| 2024 | -1.18x | $-105.96 Million | $-109.07 Million | $89.74 Million | ▼ -116.6% |
| 2023 | -0.55x | $-81.59 Million | $-91.41 Million | $149.67 Million | ▼ -709.9% |
| 2022 | 0.09x | $43.70 Million | $29.72 Million | $488.91 Million | ▼ -42.6% |
| 2021 | 0.16x | $27.16 Million | $24.26 Million | $174.54 Million | — |